Itron (NASDAQ:ITRI) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of their ...
Itron remains a buy-rated stock, following my assessment of its revenue and cash flows. ITRI's FY25 turnover guidance was weaker than expected; I think that this is a case of delayed backlog ...
A year ago, I believed that Itron (NASDAQ:ITRI) was delivering a great performance, yet the performance was soft on the bookings side. Mindful of potential softness in the 2025 results due to softer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback